Medicina
Faculty
Henry Ford Hospital
Detroit, Estados UnidosPublications in collaboration with researchers from Henry Ford Hospital (21)
2023
2022
-
Sex differences in treatment strategy for coronary artery aneurysms: Insights from the international Coronary Artery Aneurysm Registry
Netherlands Heart Journal, Vol. 30, Núm. 6, pp. 328-334
2019
-
An international perspective on hospitalized patients with viral community-acquired pneumonia
European Journal of Internal Medicine, Vol. 60, pp. 54-70
-
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention: A Global Expert Consensus Document
Circulation, Vol. 140, Núm. 5, pp. 420-433
-
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
Journal of Infection, Vol. 79, Núm. 4, pp. 300-311
-
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170
2018
-
Microbiological testing of adults hospitalised with community-acquired pneumonia: An international study
ERJ Open Research, Vol. 4, Núm. 4
-
Synchronic Diagnosis of Non-Hodgkin Lymphoma and Lung Adenocarcinoma via EBUS-guided TBNA
Journal of Bronchology and Interventional Pulmonology
2016
-
Diagnostic yield and complications of bronchoscopy for peripheral lung lesions: Results of the AQuIRE registry
American Journal of Respiratory and Critical Care Medicine, Vol. 193, Núm. 1, pp. 68-77
2010
-
Identifying predictors of central nervous system disease in solid organ transplant recipientswith cryptococcosis
Transplantation, Vol. 89, Núm. 1, pp. 69-74
-
Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients
Clinical Infectious Diseases, Vol. 51, Núm. 9, pp. 1062-1069
2009
-
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis
Clinical Infectious Diseases, Vol. 49, Núm. 11, pp. 1721-1728
2008
-
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis
Antimicrobial Agents and Chemotherapy, Vol. 52, Núm. 2, pp. 735-738
-
Central nervous system cryptococcosis in solid organ transplant recipients: Clinical relevance of abnormal neuroimaging findings
Transplantation, Vol. 86, Núm. 5, pp. 647-651
-
Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen
Clinical Infectious Diseases, Vol. 46, Núm. 2
2007
-
Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality
Journal of Infectious Diseases, Vol. 195, Núm. 5, pp. 756-764
-
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST clinical status trials
Journal of the American Medical Association, Vol. 297, Núm. 12, pp. 1332-1343
2006
-
Late-onset invasive aspergillosis in organ transplant recipients in the current era
Medical Mycology, Vol. 44, Núm. 5, pp. 445-449
2005
-
Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome
Transplantation, Vol. 80, Núm. 8, pp. 1131-1133
-
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients
Clinical Infectious Diseases, Vol. 40, Núm. 12, pp. 1756-1761